[In vitro contractility of the musculature of human gallbladders with and without gallstones--relevance of the prostaglandin system for CCK regulated motoricity].
This study describes the influence of endogenous and exogenous prostaglandins upon CCK-induced motility patterns of human gallbladders with and without stones (indomethacin and nocloprost; an exogenous PGE2-analogon). From 48 gallbladders with- and 22 gallbladders without stones (control group) longitudinal muscle stripes were dissected and transferred to an organ bath and CCK, indomethacin and nocloprost dose response curves were established. In another experimental protocol, the effect of CCK after indomethacin or nocloprost preincubation is demonstrated. Moreover, specimens of gallbladders were taken for histology and gallstones for analyse. The results demonstrate that gallbladders with stones have a significant higher basic tonus and phasic activities compared to the stone-free controls. Because of these different responses to CCK, gallbladders of the stone-diseased group were divided in two groups: 64% of the gallbladders show a sensitivity and tonic response to CCK like the controls (contractors), 36% demonstrate a reduced sensitivity to CCK and only a slight tonic response (non-contractors). Indomethacin causes a fall in tonus in both stone-diseased groups. It stops spontaneous activity in the contractor and non-contractor group. With indomethacin preincubation all three groups response to CCK with a significant reduced sensitivity. CCK-induced activity is reduced in the control and contractor group. In the non-contractor group, muscle strips do not contract after indomethacin preincubation. Nocloprost induces significant contractions in the control and contractor group. In both groups, the response to CCK after nocloprost preincubation is stronger than the reaction without preincubation. In the non-contractor group, a change in tonus after nocloprost application cannot be demonstrated, there also is no response to CCK after nocloprost preincubation. These results corroborate the notion of a significant contribution of the endogenous prostaglandin system to the regulation of gallbladder motility by CCK.
Schulz
M
M
Zentren der Physiologie, Universitätsklinikum Frankfurt/M.
Hanisch
E
E
Güldütüna
S
S
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002766:Cholecystokinin / Q000502:physiology*; D002769:Cholelithiasis / Q000503:physiopathology*; D046508:Culture Techniques; D004305:Dose-Response Relationship, Drug; D005260:Female; D016473:Gallbladder Emptying / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000503:physiopathology*; D011453:Prostaglandins / Q000502:physiology*; D011461:Prostaglandins F, Synthetic / Q000494:pharmacology; D012844:Sincalide / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D011453:Prostaglandins; D011461:Prostaglandins F, Synthetic; D014665:Vasodilator Agents; C048895:nocloprost; D002766:Cholecystokinin; D012844:Sincalide; D007213:Indomethacin
In-vitro-Kontraktilitätsverhalten humaner Muskulatur von Gallenblasen mit und ohne Steinerkrankung--Relevanz des Prostaglandinsystems die CCK-regulierte Motorik.